Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by F X Claret
Activation of the P53 Pathway by the MDM2 Inhibitor Nutlin-3a Overcomes BCL2 Overexpression in a Preclinical Model of Diffuse Large B-Cell Lymphoma Associated With T(14;18)(q32;q21)
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Constitutive Control of AKT1 Gene Expression by JUNB/CJUN in ALK+ Anaplastic Large-Cell Lymphoma: A Novel Crosstalk Mechanism
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Related publications
MDM2 Inhibitor, Nutlin 3a, Induces P53 Dependent Autophagy in Acute Leukemia by AMP Kinase Activation
PLoS ONE
Multidisciplinary
Cellular Quiescence Caused by the Mdm2 Inhibitor Nutlin-3a
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
Translocations T(8;14) and T(14;18) in a Case Presenting Diffuse Large B-Cell Lymphoma.
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Medicine
A Novel T(2;6)(p12;q23) Appearing During Transformation of Follicular Lymphoma With T(18;22)(q21;q11) to Diffuse Large Cell Lymphoma
Cancer Genetics and Cytogenetics
Presence of Simian Virus 40 in Diffuse Large B-Cell Lymphomas in Tunisia Correlates With Germinal Center B-Cell Immunophenotype, T(14;18) Translocation, and P53 Accumulation
Modern Pathology
Forensic Medicine
Pathology
Clinical Significance of T-Cell Exhaustion in Patients With Diffuse Large B-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Overexpression of FoxM1 Offers a Promising Therapeutic Target in Diffuse Large B-Cell Lymphoma
Haematologica
Hematology
Diffuse Large B-Cell Lymphoma
Direct Costs Associated With Relapsed Diffuse Large B‐Cell Lymphoma Therapies
Oncologist
Cancer Research
Medicine
Oncology
